Advances in cancer research and treatment have been transformative, offering new hope for patients worldwide. Breakthroughs in immunotherapy have enabled treatments that harness the body's immune system to target and destroy cancer cells more effectively. Targeted therapies, which focus on specific molecules involved in cancer growth, have made it possible to personalize treatment plans, minimizing side effects and improving outcomes. Additionally, advancements in precision medicine are allowing for more accurate diagnosis and tailored therapies based on an individual’s genetic makeup. Clinical trials continue to explore innovative approaches, such as gene editing and cancer vaccines, which promise even greater potential for remission and prevention. These evolving treatments bring us closer to a future where cancer may become a manageable or even curable condition, significantly improving the quality of life for patients.
Title :
Pietro Salvatori, Private Practice, Italy
Title :
Jianhua Luo, University of Pittsburgh, United States
Title :
Marika Crohns, Sanofi, Germany
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom